Clinical trial
Early Integration of Palliative and Supportive Care for Patients and Family Caregivers Undergoing Hematopoietic Stem Cell Transplantation or Chimeric Antigen Receptor T-Cell Therapy: A Prospective Pragmatic Randomized Clinical Trial
NCT05190653 is registered in ClinicalTrials.gov with Alberta Health Services, Calgary as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Integration of Palliative and Supportive Care for Patients and Family Caregivers Undergoing Hematopoietic Stem Cell Transplantation or Chimeric Antigen Receptor T-Cell Therapy: A Prospective Pragmatic Randomized Clinical Trial
- Lead sponsor
- Alberta Health Services, Calgary
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- April 8, 2022
- Completion date
- December 31, 2025
- Enrollment
- 152 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood cancer, chimeric antigen receptor t-cell therapy, leukemia, lymphoma, multiple myeloma, stem cell transplant complications